BioSpace News Archive

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), announces that the primary endpoint was met in two Chinese registration studies of recombinant full-human anti-PCSK-9 monoclonal antibody.

Kato Pharmaceuticals, a privately-held clinical stage biopharmaceutical company, today announced that the FDA has approved the company’s investigational new drug (IND) application to conduct human studies using Resolv ER™ for the treatment of Vitreomacular Attachment (VMA).

Regencell Bioscience Holdings Limited (NASDAQ: RGC) (“Regencell” or the “Company”) today announced the results from an analysis of a total of 37 individuals enrolled in its Evaluation and Assessment of RGC-COV19TM TCM through a Holistic approach (“EARTH”) efficacy trial conducted by Regencell Bioscience Asia Limited (“Regencell Asia”) of its novel COVID-19 oral TCM candidate RGC-COV19TM (Regencell Bioscience (RGCA-CV01) liquid formulation).

CANbridge Pharmaceuticals, Inc. announced that it has appointed Lan Hu, Ph.D. as the independent, nonexecutive Director of the Board of Directors and member of the remuneration committee, effective as of February 16, 2022.

Health Canada is advising patients who use MiniCap Extended Life Peritoneal Dialysis Transfer Sets, manufactured by Baxter Corporation, that direct contact between the sets and certain cleaning products, including hand sanitizers and solvents, may damage the sets.

Scientists have found whole genome sequencing (WGS) can quickly and accurately detect the most common inherited neurological disorders – something previously thought to be impossible – with the results supporting the use of WGS as a standard diagnostic tool within routine clinical practice.

Counties that introduced a mask mandate early in the pandemic experienced lower COVID-19 case incidence in the six weeks after introduction compared to counties without mandates, according to a new study in Health Affairs from researchers at PolicyLab at Children’s Hospital of Philadelphia (CHOP) and the University of Pennsylvania’s Perelman School of Medicine.

Moderna, Inc. announced that the Therapeutic Goods Administration in Australia has granted provisional registration for the use of Moderna’s mRNA COVID-19 vaccine, Spikevax, in a 50 µg dose, two-dose series, for active immunization to prevent COVID-19 caused by SARS-CoV-2 in children aged 6-11 years.

Over the past decade, neurointerventional techniques have gained increased significance in the management of acute ischemic strokes.

Hemangioma is a red color birthmark, usually appearing in the first and the second week of birth.